Nov 20O396.74H399.43L377.90C379.10Vol327.8k
Madrigal Pharmaceuticals Inc stock is traded at $379.10, with a volume of 327,825. It is down -4.45% in the last 24 hours and down -18.92% over the past month. Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Previous Close:
$396.74
Open:
$396.74
24h Volume:
327,825
Relative Volume:
0.75
Market Cap:
$8.81B
Revenue:
$1.13B
Net Income/Loss:
-$309.44M
P/E Ratio:
-
EPS:
-$12.80
Net Cash Flow:
-$275.41M
1W Performance:
-11.30%
1M Performance:
-18.92%
6M Performance:
-26.17%
1Y Performance:
-30.07%
1-Day Range:
$377.90$399.43
1-Week Range:
$377.90$429.94
52-Week Range:
$353.54$615.00
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Name
Madrigal Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
404-380-9263Address
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS